AMERICAN JOURNAL OF LAW & MEDICINE is a prestigious interdisciplinary journal published by Cambridge University Press that bridges the critical intersection of legal and medical scholarship. Since its inception in 1975, this journal has fostered scholarly dialogue surrounding complex legal issues affecting health care and medical ethics, significantly contributing to the fields of law and the social sciences. With its current impact factor highlights showcasing a Q2 ranking in Law and Q3 in Health (Social Science), along with a solid readership base, the journal appeals to researchers, legal professionals, and students alike, offering a platform for impactful research and case studies. Although it does not currently provide Open Access options, the journal continues to prioritize rigorous peer-reviewed content, ensuring that essential discussions on law and medicine remain accessible to its readership. By engaging with contemporary legal and medical issues, the AMERICAN JOURNAL OF LAW & MEDICINE plays a vital role in advancing knowledge and shaping practices within these dynamic fields.

THEORETICAL MEDICINE AND BIOETHICS, published by SPRINGER, is an esteemed journal dedicated to exploring the complex intersections of medicine, ethics, and law. With its ISSN 1386-7415 and E-ISSN 1573-1200, this journal serves as a vital platform for scholars, practitioners, and students interested in the ethical implications of medical practices and innovations. Although it currently holds a Q4 impact factor in the categories of Issues, Ethics and Legal Aspects and Medicine (Miscellaneous) as of 2023, its relevance is amplified by its commitment to fostering critical discourse in a rapidly evolving field. The journal features a diverse range of articles that address profound ethical dilemmas in healthcare, making it a significant resource for contemporary research from 1997 to the present. As an open-access journal, it ensures that cutting-edge knowledge is readily available, inviting contributions that challenge conventional thought and advance the field of bioethics.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

Linacre Quarterly, published by SAGE Publications Inc, is a distinguished journal that serves as an interdisciplinary platform in the fields of Health Policy and Philosophy. With an ISSN of 0024-3639 and an E-ISSN of 2050-8549, this journal has been pivotal in providing insights into the intricate dynamics of health policy through a philosophical lens since its inception in 1945. Notably, it holds a respectable 2023 Scopus rank, placing it in the 68th percentile within the Arts and Humanities (Philosophy) category and the 21st percentile in Medicine (Health Policy). Though currently not offering Open Access options, Linacre Quarterly remains committed to advancing scholarly discussion and fostering innovation among researchers, professionals, and students alike. Located in the United Kingdom, this journal continues to uphold its reputation as a vital resource for those navigating the complexities of health-related ethical dilemmas and policy-making frameworks, thereby enhancing its visibility and relevance in academic discourse.

The Journal of Bioethical Inquiry, published by Springer, is a prominent academic journal in the fields of bioethics, health policy, and social sciences. Established in 2004 and running through 2024, it is recognized for providing a critical platform for the exploration of ethical issues arising in the contexts of healthcare and policy making. With an ISSN of 1176-7529 and an E-ISSN of 1872-4353, this esteemed journal holds a Q2 quartile ranking in both Health Policy and Health (Social Science) categories, indicating its significant impact and contributions to the field. It boasts impressive Scopus rankings, with a standing of #70 out of 371 in Social Sciences _ Health (Social Science) and #68 out of 310 in Medicine _ Health Policy, representing its relevance and authority in these domains. Although it does not currently offer open access options, the Journal of Bioethical Inquiry remains a vital resource for researchers, practitioners, and students eager to engage with the complexities of bioethical challenges and to advance the discourse on health policies.

ISSUES IN LAW & MEDICINE, published by the NATIONAL LEGAL CENTER MEDICALLY DEPENDENT & DISABLED INC, serves as a vital resource within the intersecting realms of legal and medical discourse. With an ISSN of 8756-8160, this journal has been in circulation since 1985 and continues to provide insights and analyses relevant to both health policy and the ethical implications of medical practice. Despite its categorization in the fourth quartile among peers, it remains a crucial platform for exploring underrepresented issues that affect medically dependent and disabled populations. Each issue aims to contribute to knowledge and inform practice in areas such as ethics, legal considerations, and health care policy, promoting greater understanding among researchers, professionals, and students alike. While access is not open, the journal's ongoing commitment to addressing complex topics positions it as a relevant source for those dedicated to advancing the conversation at the intersection of law and medicine.

MEDICINE SCIENCE AND THE LAW is a prestigious journal published by SAGE PUBLICATIONS INC, focused on the intersection of law, health policy, and ethical issues as they pertain to medicine. With a long-standing history dating back to 1960, this journal has become a crucial platform for scholars and professionals alike to share and disseminate research that shapes the evolving legal landscape surrounding health care practices. It holds notable positions in the academic community, ranking in the Q3 category for Health Policy and Issues, Ethics and Legal Aspects, and achieving a distinguished Q1 ranking in Law as of 2023. With rigorous peer-review standards and a commitment to publishing high-quality research, MEDICINE SCIENCE AND THE LAW is invaluable for those exploring the critical legal challenges and ethical dilemmas faced within the healthcare sector. Research contributions are vital for informing policy and practice, ensuring that the journal remains a relevant and essential resource for researchers, practitioners, and students dedicated to the intersection of law and medicine.

Cuadernos de Bioetica, published by the ASOC ESPANOLA BIOETICA & ETICA MEDICA, is a prominent academic journal dedicated to exploring significant philosophical, ethical, and legal dimensions within the field of bioethics. With an ISSN of 1132-1989 and an E-ISSN of 2386-3773, this journal serves as a vital platform for researchers, professionals, and students in medicine and related disciplines. Since its inception in 2008, it has consistently provided critical analyses and discussions reflecting the evolving landscape of healthcare ethics, contributing notably to the discourse surrounding ethical practices in medicine. Despite its current Q4 ranking in the miscellaneous medicine category, Cuadernos de Bioetica is committed to enhancing its impact and relevance, making it an essential resource for those seeking to navigate the complex ethical challenges in contemporary medical practice. The journal’s reach is underscored by its commitment to fostering open dialogue among diverse stakeholders in the field, encouraging a broad spectrum of contributions to advance knowledge in bioethics.

CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS is a premier journal published by Cambridge University Press, focusing on significant issues at the intersection of healthcare, ethics, and policy. With an ISSN of 0963-1801 and an E-ISSN of 1469-2147, this journal serves as a vital platform for discourse among researchers, practitioners, and scholars in the health social sciences. Emphasizing vital ethical considerations in healthcare practices and policies, it ranks in the Q3 tier for Health Policy and Q2 for both Health (Social Science) and Issues, Ethics, and Legal Aspects according to the 2023 journal category quartiles. The journal, spanning its tenure from 1992 to 2024, features rigorous peer-reviewed articles that contribute to the advancement of ethical standards in healthcare. By addressing contemporary ethical dilemmas and promoting scholarly dialogue, CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS remains an essential resource for those committed to understanding the complexities and ethical implications inherent in health systems today.